Recent advances in therapeutic targets identification and development of treatment strategies towards Pseudomonas aeruginosa infections

DRA Sanya, D Onésime, G Vizzarro, N Jacquier - BMC microbiology, 2023 - Springer
The opportunistic human pathogen Pseudomonas aeruginosa is the causal agent of a wide
variety of infections. This non-fermentative Gram-negative bacillus can colonize zones …

Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics

S Qin, W Xiao, C Zhou, Q Pu, X Deng, L Lan… - Signal transduction and …, 2022 - nature.com
Pseudomonas aeruginosa (P. aeruginosa) is a Gram-negative opportunistic pathogen that
infects patients with cystic fibrosis, burn wounds, immunodeficiency, chronic obstructive …

Novel therapeutic strategies to counter Pseudomonas aeruginosa infections

JL Fothergill, C Winstanley… - Expert review of anti …, 2012 - Taylor & Francis
Pseudomonas aeruginosa is a highly successful opportunistic pathogen that displays
intrinsic multidrug resistance and has a tremendous capacity to acquire further resistance …

[HTML][HTML] Pseudomonas aeruginosa: Infections and novel approaches to treatment “Knowing the enemy” the threat of Pseudomonas aeruginosa and exploring novel …

N Sathe, P Beech, L Croft, C Suphioglu, A Kapat… - Infectious Medicine, 2023 - Elsevier
Pseudomonas aeruginosa is an aerobic Gram-negative rod-shaped bacterium with a
comparatively large genome and an impressive genetic capability allowing it to grow in a …

Targeting mechanisms of Pseudomonas aeruginosa pathogenesis

E Kipnis, T Sawa, J Wiener-Kronish - Medecine et maladies infectieuses, 2006 - Elsevier
Pseudomonas aeruginosa is an opportunistic pathogen responsible for ventilator-acquired
pneumonia, acute lower respiratory tract infections in immunocompromised patients and …

The Therapeutic Pipeline for Pseudomonas aeruginosa Infections

LL Burrows - ACS infectious diseases, 2018 - ACS Publications
Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen, designated by the
World Health Organization as a critical priority for development of new therapeutics due to …

Pseudomonas aeruginosa : new insights into pathogenesis and host defenses

SL Gellatly, REW Hancock - Pathogens and disease, 2013 - academic.oup.com
Pseudomonas aeruginosa is a metabolically versatile bacterium that can cause a wide
range of severe opportunistic infections in patients with serious underlying medical …

Emerging strategies to target virulence in Pseudomonas aeruginosa respiratory infections

TM Hibbert, M Whiteley, SA Renshaw… - Critical reviews in …, 2023 - Taylor & Francis
Pseudomonas aeruginosa is an opportunistic pathogen that is responsible for infections in
people living with chronic respiratory conditions, such as cystic fibrosis (CF) and non-CF …

Pseudomonas aeruginosa virulence and therapy: evolving translational strategies

JL Veesenmeyer, AR Hauser, T Lisboa… - Critical care …, 2009 - journals.lww.com
Objective: Although most reviews of Pseudomonas aeruginosa therapeutics focus on
antibiotics currently in use or in the pipeline, we review evolving translational strategies …

The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update

D Reynolds, M Kollef - Drugs, 2021 - Springer
Pseudomonas aeruginosa is a Gram-negative bacterial pathogen that is a common cause of
nosocomial infections, particularly pneumonia, infection in immunocompromised hosts, and …